CAPSTAN THERAPEUTICS, INC.

Profile

Company Names

CAPSTAN THERAPEUTICS, INC.

Addresses

9880 CAMPUS POINT DRIVE, SUITE 220, SAN DIEGO, CA 92121

Phone Numbers

858-314-9188

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$226,999,957.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-03-05 
$87,499,982.00 
$174,999,964.00 
$87,499,982.00 
Equity 
2
2022-06-14 
$76,499,983.00 
$101,999,962.00 
$25,499,979.00 
Equity 
1
2021-11-24 
$62,999,992.00 
$62,999,992.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MICHAEL 
 
BARAN 
DIRECTOR
MAGNOLIA NEUROSCIENCES CORP   |  MEDIAR THERAPEUTICS, INC.   |  CAPSTAN THERAPEUTICS, INC.   |  TREX HOLDINGS INC.   |  AFFINITY HEALTHCARE STRATEGIC OPPORTUNITIES FUND, LP
ADRIAN 
 
BOT 
EXECUTIVE OFFICER
CAPSTAN THERAPEUTICS, INC.
EREZ 
 
CHIMOVITS 
DIRECTOR
ORBIMED ISRAEL PARTNERS LIMITED PARTNERSHIP   |  ADICET BIO, INC.   |  LOGICBIO THERAPEUTICS, INC.   |  ATOX BIO INC.   |  NOVUS THERAPEUTICS, INC.   |  ADARX PHARMACEUTICALS, INC.   |  IMMPACT BIO USA INC.   |  GALECTO, INC.   |  FORE US BIO INC.   |  CAPSTAN THERAPEUTICS, INC.
ATHENA 
 
COUNTOURIOTIS 
DIRECTOR
AMBIT BIOSCIENCES CORP   |  TROVAGENE, INC.   |  AVENZO THERAPEUTICS, INC.   |  CAPSTAN THERAPEUTICS, INC.
RAMIN 
 
FARZANEH-FAR 
EXECUTIVE OFFICER
PEPGEN INC.   |  LUSARIS THERAPEUTICS, INC.   |  CAPSTAN THERAPEUTICS, INC.
RAJUL 
 
JAIN 
DIRECTOR
NEOGENE THERAPEUTICS, INC.   |  LB PHARMACEUTICALS INC   |  CAPSTAN THERAPEUTICS, INC.   |  QUANTA THERAPEUTICS, INC.   |  SONOTHERA, INC.
PRIYA 
 
KARMALI 
EXECUTIVE OFFICER
CAPSTAN THERAPEUTICS, INC.
NANNA 
 
LUNEBORG 
DIRECTOR
STARGAZER PHARMACEUTICALS, INC.   |  CAPSTAN THERAPEUTICS, INC.   |  MAPLIGHT THERAPEUTICS, INC.
FABIO 
 
PUCCI 
DIRECTOR
INDAPTA THERAPEUTICS INC.   |  CAPSTAN THERAPEUTICS, INC.
NANDITA 
 
SHANGARI 
DIRECTOR
TSCAN THERAPEUTICS, INC.   |  MEDIAR THERAPEUTICS, INC.   |  CAPSTAN THERAPEUTICS, INC.   |  HALDA THERAPEUTICS, LLC
LAURA 
 
SHAWVER 
EXECUTIVE OFFICER, DIRECTOR
PHENOMIX CORP   |  CORNERSTONE THERAPEUTICS INC   |  CLEAVE BIOSCIENCES, INC.   |  SYNTHORX, INC.   |  SILVERBACK THERAPEUTICS, INC.   |  RELAY THERAPEUTICS, INC.   |  CAPSTAN THERAPEUTICS, INC.   |  BRIGHT PEAK THERAPEUTICS, INC.
MICHAL 
 
SILVERBERG 
DIRECTOR
GALERA THERAPEUTICS, INC.   |  TWENTYEIGHT-SEVEN, INC.   |  ADICET BIO, INC.   |  IMMPACT BIO USA INC.   |  REDONA THERAPEUTICS, INC.   |  FORE US BIO INC.   |  CAPSTAN THERAPEUTICS, INC.   |  ONL THERAPEUTICS, INC.   |  AVERNA THERAPEUTICS INC.
KAREN 
 
SMITH 
DIRECTOR
CAPSTAN THERAPEUTICS, INC.
JUSTIN 
 
THACKER 
EXECUTIVE OFFICER
CAPSTAN THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-03-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-14 
2024-03-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-03-05 
2024-03-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#